Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects

Published:2015-07-27 Issue:9 Volume:14 Page:1421-1434
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Esposito Isabella,Labarga Pablo,Barreiro Pablo,Fernandez-Montero José V,de Mendoza Carmen,Benítez-Gutiérrez Laura,Peña José M,Soriano Vicente

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14740338.2015.1073258

Reference95 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus infection

2. Towards hepatitis C eradication from the HIV-infected population

3. Trouble with Bleeding: Risk Factors for Acute Hepatitis C among HIV-Positive Gay Men from Germany—A Case-Control Study

4. Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus;World Journal of Gastroenterology;2023-03-21

2. Pathophysiological and Genetic Basis of Tenofovir-Induced Acute Renal Dysfunction: Strategies and Recent Developments for Better Clinical Outcomes;Current Pharmacology Reports;2022-08-30

3. Predicting Binding Affinity Between MHC-I Receptor and Peptides Based on Molecular Docking and Protein-peptide Interaction Interface Characteristics;Letters in Drug Design & Discovery;2022-08-19

4. Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy;Pharmaceuticals;2022-03-15

5. Current Overviews on COVID-19 Management Strategies;Current Pharmaceutical Biotechnology;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3